News & Updates
Filter by Specialty:
Tenapanor improves symptoms in patients with IBS-C
Treatment with tenapanor improves symptoms in patients with irritable bowel syndrome with constipation (IBS-C) as early as week 1 of treatment, according to two phase III studies presented at DDW 2022.
Tenapanor improves symptoms in patients with IBS-C
07 Jun 2022
High depressive symptoms at multiple timepoints carry elevated stroke risk
Among individuals who have undergone repeated assessments for depression, the presence of high symptoms at multiple timepoints raises the risk of developing stroke, according to a study.
High depressive symptoms at multiple timepoints carry elevated stroke risk
06 Jun 2022
Imatinib may reduce mortality in hospitalized COVID-19 patients
The tyrosine kinase inhibitor imatinib may reduce mortality in patients hospitalized with severe COVID-19, according to follow-up results of the CounterCOVID study presented at ATS 2022.
Imatinib may reduce mortality in hospitalized COVID-19 patients
06 Jun 2022
Antibiotics identified as culprit for older-onset IBD
Antibiotic use appears to be harmful for older adults, with a recent study showing that regardless of class, the drugs raise the risk of developing inflammatory bowel disease (IBD).
Antibiotics identified as culprit for older-onset IBD
06 Jun 2022
Polycythemia ups risk of MACE, VTE in men on testosterone therapy
Men receiving testosterone therapy (TT) who develop polycythemia are at greater risk for major adverse cardiovascular events (MACE) and venous thromboembolism (VTE) in the first year of therapy, according to a recent study.